OICHARTS
8 AMThe 8 AM report →

Pharma

278 bulletins

Nearby sectors

Thu 1 OctAfter close

Ajanta Pharma promoters pledge shares for ₹3,873 crore debtPharmaMediumAJANTPHARM

Tue 29 SeptAfter close

Anupam Rasayan completes Bliss GVS Pharma acquisitionPharma · ChemicalsHighANUPAMRA

Tue 29 SeptPre-market

Nifty 50 declines as bond yields rise and risks escalateBanking · PharmaHighDRREDDY Stocks poised to gain from falling rupeePharma · ITMediumINDOGENE

Mon 28 SeptAfter close

Sanofi Healthcare acquires 15.2% stake in Sanofi IndiaPharmaHighSANOFIINDIA

Sat 26 SeptAfter close

RPG Active Pharma approves merger with Actis GenericsPharmaMediumRPG

Fri 25 SeptAfter close

Natco Pharma announces ₹1,279 crore rights issue detailsPharmaMediumNATCOPHARM

Fri 25 SeptPre-market

Dr. Reddy's faces fraud probe after Q1 earnings dropPharmaHighDRREDDY

Tue 22 SeptAfter close

IOL Chemicals plans ₹500 Cr investment for growthPharma · ChemicalsMediumIOLCP

Tue 22 SeptPre-market

IOL Chemicals invests ₹500 Cr for growth in pharmaceuticalsPharma · ChemicalsMediumIOLCP

Mon 21 SeptPre-market

Sensex, Nifty open lower amid crude oil price riseOil & Gas · PharmaMediumDRREDDY

Sun 20 SeptAfter close

India New Zealand trade deal boosts Supriya Lifescience prospectsPharma · ChemicalsMediumSUPRIYA Sensex, Nifty open lower amid geopolitical tensionsOil & Gas · PharmaMediumDRREDDY

Sun 20 SeptPre-market

Gujarat Themis completes ₹1,200 crore acquisition of MicroBiopharmPharmaHighGTBL

Sat 19 SeptPre-market

Abbott India stock rallies on strong earnings reportPharmaHighABBOTTINDIA Gujarat Themis Biosyn acquires MicroBiopharm to enhance capabilitiesPharmaHighGTBL

Fri 18 SeptAfter close

Granules India promoter sells 7% stake for ₹1,500 crorePharmaHighGRANULES

Thu 17 SeptAfter close

Dr Reddy's Q1FY27 results show revenue decline and margin pressuresPharmaMediumDRREDDY

Wed 16 SeptPre-market

Granules India promoter sells 6.9% stake for ₹1,509 crorePharmaMediumGRANULES

Tue 15 SeptAfter close

Granules India promoter sells 6.9% stake for ₹1,509 crorePharmaMediumGRANULES

Wed 19 AugAfter close

Piramal Pharma acquires controlling stake in Yapan BioPharma · BiotechnologyHighPPLPHARMA

Wed 19 AugPre-market

Piramal Pharma acquires controlling stake in Yapan BioPharma · HealthcareHighPPLPHARMA

Tue 18 AugPre-market

JPMorgan raises Alkem Laboratories target to ₹6,100PharmaMediumALKEM

Mon 17 AugAfter close

JPMorgan raises Alkem target price to ₹6,100, maintains Neutral ratingPharmaMediumALKEM Indian equities open lower as Sensex drops over 300 pointsIT · PharmaHigh Anupam Rasayan raises FY27 revenue growth guidance to over 30%Pharma · ManufacturingMediumANUPAMRASAYAN

Sun 16 AugAfter close

Nifty outlook shows continued weakness amid consolidationFinancial Services · PharmaMedium

Sun 26 JulPre-market

Sun Pharma's $9.4 billion Organon acquisition approvedPharmaHighSUNPHARMA

Fri 24 JulAfter close

Laurus Labs Q1 results show strong growth and margin expansionPharmaHighLAURUSLABS Organon shareholders approve Sun Pharma's $11.75 billion acquisitionPharmaHighSUNPHARMA